What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
When Joe Biden ran for president in 2020, he promised to allow Medicare to negotiate directly with pharmaceutical companies. Last year, he signed the Inflation Reduction Act into law and achieved that campaign promise.
On Tuesday, the Biden Administration announced the 10 prescription medications that will first be included in negotiations between drugmakers and the Centers for Medicare Medicaid Services (CMS). What impact will Medicare price negotiations have on big pharma stocks? Let's dive in.
It's important to first understand exactly which big pharma stocks could be affected by Medicare price negotiations. Here are the drugs on the initial list released by the White House along with the companies that market them:
Source Fool.com
China Medical System Holdings Ltd Aktie
0,89 €
5,95 %
